Mirum Pharmaceuticals (MIRM) Inventory Average (2022 - 2026)

Mirum Pharmaceuticals' Inventory Average history runs 5 years deep, the most recent figure standing at $25.2 million for Q1 2026.

• On a quarterly basis, Inventory Average rose 12.46% year-over-year to $25.2 million in Q1 2026; TTM through Mar 2026 was $25.2 million, a 12.46% increase from a year earlier, with the FY2025 full-year figure at $23.6 million, up 5.76% from the prior year.
• Inventory Average advanced to $25.2 million in Q1 2026 per MIRM's latest filing, from $24.5 million in the prior quarter.
• Across five years, Inventory Average topped out at $25.2 million in Q1 2026 and bottomed at $1.5 million in Q1 2022.
• The 5-year median for Inventory Average is $21.0 million (2024), against an average of $16.0 million.
• Across the five-year window, Inventory Average jumped 293.73% in 2023 and fell 1.27% in 2024, its largest moves.
• Year by year, Inventory Average stood at $6.3 million in 2022, then soared by 256.27% to $22.3 million in 2023, then fell by 1.27% to $22.0 million in 2024, then rose by 11.16% to $24.5 million in 2025, then advanced by 3.06% to $25.2 million in 2026.
• Per Business Quant, the three latest MIRM Inventory Average figures stand at $25.2 million (Q1 2026), $24.5 million (Q4 2025), and $23.5 million (Q3 2025).